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Abstract
Background: Hematopoiesis is a complex developmental process controlled by a large number of factors
that regulate stem cell renewal, lineage commitment and differentiation. Secreted proteins, including the
hematopoietic growth factors, play critical roles in these processes and have important biological and
clinical significance. We have employed representational difference analysis to identify genes that are
differentially expressed during experimentally induced myeloid differentiation in the murine EML
hematopoietic stem cell line.
Results: One identified clone encoded a previously unidentified protein of 541 amino acids that contains
an amino terminal signal sequence but no other characterized domains. This protein is a member of family
of related proteins that has been named family with sequence similarity 20 (FAM20) with three members
(FAM20A, FAM20B and FAM20C) in mammals. Evolutionary comparisons revealed the existence of a
single FAM20 gene in the simple vertebrate Ciona intestinalis and the invertebrate worm Caenorhabditis
elegans and two genes in two insect species, Drosophila melanogaster and Anopheles gambiae. Six FAM20
family members were identified in the genome of the pufferfish, Fugu rubripes and five members in the
zebrafish, Danio rerio. The mouse Fam20a protein was ectopically expressed in a mammalian cell line and
found to be a bona fide secreted protein and efficient secretion was dependent on the integrity of the signal
sequence. Expression analysis revealed that the Fam20a gene was indeed differentially expressed during
hematopoietic differentiation and that the other two family members (Fam20b and Fam20c) were also
expressed during hematcpoiesis but that their mRNA levels did not vary significantly. Likewise FAM20A
was expressed in more limited set of human tissues than the other two family members.
Conclusions: The FAM20 family represents a new family of secreted proteins with potential functions in
regulating differentiation and function of hematopoietic and other tissues. The Fam20a mRNA was only
expressed during early stages of hematopoietic development and may play a role in lineage commitment
or proliferation. The expansion in gene number in different species suggests that the family has evolved as
a result of several gene duplication events that have occurred in both vertebrates and invertebrates.
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Background
Hematopoietic differentiation is a complex process
whereby multiple functionally and morphologically dis-
tinct cell types arise from a population of pluripotent
hematopoietic stem cells (PHSCs) [1]. The accurate and
efficient regulation of hematopoietic development is con-
trolled by a large number of regulatory proteins that have
been identified over the past few decades. These regula-
tory molecules include the hematopoietic growth factors
(HGFs), soluble proteins that recognize specific receptors
on the surface of sub-populations of hematopoietic cells,
thereby initiating signal transduction pathways that mod-
ulate the differentiation, proliferation, and/or survival of
target cells [2]. The identification of regulators of hemat-
opoiesis has been an ongoing effort for many years and
has benefited from the existence of accessible cell line
models as well as the characterization of genes affected by
somatic mutations associated with specific human leuke-
mias [3].
We have used a pair of factor-dependent murine cell lines
to identify novel genes expressed within distinct hemat-
opoietic lineages as an approach to the identification of
novel candidate genes for development of diagnostic and
therapeutic approaches to leukemia. The EML and MPRO
cell lines were both established by infecting murine bone
marrow cells with a retrovirus expressing a dominant neg-
ative retinoic acid receptor α (RARα) protein [4,5]. The
infected cells were selected in the presence of either stem
cell factor (SCF) or granulocyte/macrophage colony stim-
ulating factor (GM-CSF). EML are SCF-dependent and
resemble uncommitted hematopoietic progenitor cells.
They can be induced to differentiate to the promyelocyte
stage of granulopoiesis in the presence of interleukin-3
(IL-3) and high doses of all trans retinoic acid (atRA)
[4,6]. Terminal neutrophil differentiation of EML cells can
be induced by replacement of IL-3 and SCF with GM-CSF.
MPRO cells are GM-CSF-dependent and can be induced to
differentiate to neutrophils by adding high doses of atRA
to the culture medium. The expression patterns of a
number of genes expressed during hematopoiesis have
been examined in EML and MPRO cells and generally
agree with the patterns observed in other cell systems and
in primary hematopoietic cells. Thus, EML and MPRO
provide a powerful system for the identification and char-
acterization of novel genes expressed within the hemat-
opoietic lineage.
We have employed the representation difference analysis
technique [7] to identify cDNAs representing genes
expressed at higher levels in EML cells 72 hours after
induction of differentiation than in uninduced cells. We
describe the identification of a clone derived from an
uncharacterized putative secreted protein. We have per-
formed a comparative genomics analysis and determined
that this protein is the founding member of an extended
family of highly related proteins. This family contains
three members in mammalian species, one or two mem-
bers in invertebrate or simple vertebrate species and five
or six members in fish. We have determined that one fam-
ily member is a secreted glycoprotein and describe the
expression pattern of the human and mouse genes in tis-
sues and during hematopoietic differentiation.
Results
Identification of differentially expressed genes by 
representational difference analysis (RDA)
Total RNA was prepared from EML cells grown in the pres-
ence of SCF alone (0 hour) or in medium supplemented
with IL-3 and atRA for 72 hours. The RNA was converted
to cDNA and subjected to three rounds of RDA as previ-
ously described [6]. Six differentially-expressed clones
were identified [6,8]. Clone number 1623 was chosen for
further analysis and the differential expression of this gene
was confirmed by Northern blot analysis. 1623 mRNA
was essentially undetectable in the 0 hour sample but
readily detectable in the 72 hour sample (data not shown
and see figure 10).
Sequence analysis of clone 1623
The initial cDNA isolated by RDA was a 273 bp fragment
that appeared to contain the coding sequence of the C-ter-
minus of a protein that was not present at that time in
public databases. To identify the full open reading frame
of this cDNA, we first performed rapid amplification of
cDNA ends (RACE) in both the 5' and 3' directions. Exten-
sion in the 3' direction revealed the presence of a consen-
sus polyadenylation signal located 154 nucleotides
downstream of the putative translation stop codon. Exten-
sion in the 5' direction yielded an additional 443 bp of
sequence containing a contiguous ORF. Comparison of
this extended sequence to public databases identified a
cDNA (NM_017565) that was identical to clone 1623 in
the region of overlap. This cDNA was isolated from a
mouse mammary tumor but no functional analysis had
been performed. We designed PCR primers based on the
published sequence and confirmed that the cDNA iso-
lated from EML cells was identical to the published
sequence. The full length ORF was 1623 bp in length and
encoded a protein of 541 amino acids (Figure 1A). The
protein did not contain any recognizable motifs when
examined using domain mapping software such as
SMART or Profilescan (see Methods). However, a putative
amino terminal signal sequence was identified using the
SignalP analysis program. The cDNA mapped to an 11
exon gene located on mouse chromosome 11E1 (Figure
1B). The gene spanned approximately 60,000 bp of
genomic sequence and the relatively large size of the gene
is primarily due to the fact that the first intron is greater
than 44,000 bp in length (Figure 1C).BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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Characterization of the full length mouse 1623 (Fam20a) cDNA and genomic sequence Figure 1
Characterization of the full length mouse 1623 (Fam20a) cDNA and genomic sequence. A. The full length cDNA 
derived from the original RDA clone was isolated using a combination of 5' and 3' rapid amplification of cDNA ends (RACE) 
procedures, comparisons to public databases, and amplification of putative full length clones by PCR. The full open reading 
frame was 1623 bp in length and encoded a 541 amino acid protein. The locations of regions conserved within the subse-
quently identified FAM20 family are indicated using underlines. Eight cysteine residues that are also conserved within the family 
are indicated in bold and four putative N-glycosylation sites are indicated in red type. B. The distribution of the 11 exons of the 
mouse Fam20a gene is shown with the exons indicated using numbers. A consensus polyadenylation signal is located down-
stream of the terminal exon. C. The sizes of the 11 exons and 10 introns of the Fam20a gene are shown.
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Identification of a family of related genes
The full length cDNA and the encoded protein were com-
pared to sequences in public databases. We reported pre-
viously a weak similarity to a protein named Fjx1, which
is the mouse orthologue of a Drosophila protein named
four-jointed [8]. However, the degree of sequence identity
between these proteins was low (16%) and thus the
search was extended to include uncharacterized proteins.
We first identified two other mouse proteins that dis-
played significant similarity to, but were distinct from, the
query sequence. One protein (Accession number
NP_663388 aka Riken C530043G21) was 409 amino
acids in length and displayed 27% identity to the query
sequence while the second (NP_085042) was a truncated
version of a 579 amino acid protein that displayed 40%
identity to the query sequence. We have subsequently dis-
covered that these proteins are members of a highly
related family and this family has received the official
name "family with sequence similarity 20" (FAM20) from
the Human Genome Organization Gene Nomenclature
Committee. The protein derived from our original 1623
cDNA is named Fam20a in mouse and the other two fam-
ily members are named Fam20b and Fam20c, respec-
tively. Continued searches of public databases revealed
the existence of related proteins in several other species.
Each mammalian genome contains genes encoding three
members that are orthologous to the three mouse pro-
teins mentioned above. The accession numbers for the rel-
evant cDNAs in human and rat are listed in Table 1 and
we have also identified the same number of related
sequences in other mammalian genomes, including the
pig, cow and dog (data not shown). However, most of
these sequences are incomplete and will not be described
in detail here.
In order to gain further information concerning the origin
of the FAM20 family, we searched for related sequences in
several other invertebrate and vertebrate organisms. The
ascidian Ciona intestinalis is a model for a basal chordate
organism and has emerged as a powerful model for evolu-
tionary and developmental studies [9,10]. In particular,
many gene families or subfamilies are represented by sin-
gle members in C. intestinalis and thus the identification
of an orthologue in this organism can provide useful
information for evaluating the evolutionary origin of the
members of a gene family. Consistent with this concept,
we identified a single cDNA and the corresponding
genomic locus in C. intestinalis that displayed significant
sequence similarity to the mammalian FAM20 genes and
proteins (Table 1). Complete genome sequences are also
available for several invertebrate species and two related
sequences were identified in Drosophila melanogaster and
Anopheles gambiae with one family member in Caenorhab-
ditis elegans (Table 2). Finally, analysis of genomic cDNA
and protein databases for the pufferfish (Fugu rubripes)
and zebrafish (Danio rerio) revealed the presence of six
and five family representatives, respectively (Table 1). The
gene numbers in these various species are listed on an ide-
alized evolutionary tree in Figure 2 and suggest that the
FAM20 gene family has undergone a complex set of gene
duplications in both the invertebrate and chordate
lineages.
Assignment of subfamily relationships
To elucidate the nature of these putative gene duplica-
tions, we sought to assign the individual sequences from
Table 1: Accession numbers for vertebrate FAM20 family members1
Family 
Member
Human Mouse Rat Fugu Zebrafish Ciona
FAM20A NM_017565 NM_153782 XM_221067 (BK001521) SINFRUP00000146987 (BK001515) ND ND
FAM20B NM_014864 NM_145413 XM_222770 SINFRUP00000138548 (BK001520) CAI11712 AK115425
FAM20C NM_020223 NM_030565 XM_221975 (BK001522) SINFRUP00000140879 (BK001516)
SINFRUP00000141732 (BK001518)
SINFRUP00000163431 (BK001517)
BK001519
ENSDARP00000009272
ENSDARP00000005688
ENSDARP00000028589
ND
1. Accession numbers refer to nucleotide sequences in GenBank except in the Fugu and Zebrafish listing where the accession numbers refer either 
to predicted peptides in the Ensembl database (entries beginning SINFRUP or ENSDARP) or Genbank (entry beginning CAI).
Entries beginning with BK refer to predicted sequences in the Third Party Annotation database arising from this study. ND: None detected.
Table 2: Accession numbers for invertebrate FAM20 family 
members1
Family Member Drosophila Mosquito C. elegans
FAM20A ND ND ND
FAM20B NM_170079
NM_206490
EAA08010
EAA13434
NM_078126
Fam20C ND ND ND
1. Accession numbers refer to nucleotide sequences in GenBank. ND: 
None detected.BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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the various species into subfamilies based on protein
sequence and gene structure, specifically using the
number and size of exons in the latter case. Initially, the
exon distribution of each of the Fam20 members in three
mammalian species (human, mouse and rat) was com-
pared and revealed obvious inter and intra orthologue
similarities (figure 3A). Each FAM20A gene contained 11
exons and exon sizes were identical in these three species.
Likewise, each FAM20B gene contained 7 exons that were
identical in size in human, mouse and rat. The FAM20C
genes each contained 10 exons and only exon 1 displayed
any variation in size amongst these three species. In intra-
orthologue comparisons, the exons in FAM20B and
FAM20C genes clearly aligned with exons in the FAM20A
genes, with small variations (in multiples of three bases)
in the size of the internal exons in FAM20B. FAM20B lacks
exons corresponding to exons 2–4 of FAM20A while
FAM20C lacks exon 3. In addition, exons 8 and 9 in
FAM20A and FAM20C are represented by a single exon in
FAM20B that is identical in size to the combined exons in
the other two genes. Thus, the three mammalian genes are
highly evolutionarily related and presumably are derived
from a common ancestral gene.
To assign the genes identified in other species to these
three subfamilies, we performed a global comparison of
the peptide sequences derived from 25 of the identified
family members listed in Tables 1 and 2. One zebrafish
protein (from FAM20A) was omitted as its sequence is
incomplete. A dendrogram showing the results of this
Evolutionary distribution of FAM20 gene number Figure 2
Evolutionary distribution of FAM20 gene number. An idealized evolutionary tree (modified from [10]) is shown with 
the number of FAM20 genes identified in several genomes as described in the text. The gene numbers are supportive of a single 
gene duplication event occurring in invertebrates (at least in insects) and multiple gene duplication events occurring in higher 
vertebrates.
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Assignment of FAM20 family members to subfamilies Figure 3
Assignment of FAM20 family members to subfamilies. A. Exon size and distribution of mammalian FAM20 members. 
The exons within each FAM20 gene in human, mouse and rat are indicated with the number of base pairs indicated within each 
exon. The sizes of exons that differ in size from the FAM20A genes are indicated. B. A dendrogram showing the relationships 
between FAM20 proteins from human (Hs), mouse (Mm), rat (Rn), Fugu rubripes (Fr), Danio rerio (Dr), D. melanogaster (Dm), A. 
gambiae (Ag), C. intestinalis (Ci) and C. elegans. The accession numbers of the cDNA sequences from which each protein 
sequence was derived are shown in parentheses except in the case of the mosquito family members where the accession 
number is used as the gene/protein name. Accession numbers for zebrafish peptide sequences are listed in Table 1. The FAM20 
nomenclature has not been extended to the invertebrate sequences and the previous gene names have been used for Dro-
sophila and C. elegans family members. The subfamily assignment of each family member is shown on the right. C. Exon 
number and size distribution within Fugu Fam20 members. The accession number of each sequence within the Third Party 
Annotation database is shown at left and family assignment based on dendrogram position and exon distribution is shown on 
the right.
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comparison is presented in Figure 3B. As expected, the
mammalian orthologues clustered together and thus
defined the subfamilies. All of the invertebrate proteins
and the single protein identified in C. intestinalis clustered
with FAM20B proteins, suggesting that this represents the
ancestral branch of the FAM20 family. A single protein
from Fugu and zebrafish clustered with the FAM20A and
FAM20B family members while two Fugu and two
zebrafish proteins clustered with FAM20C members.
However, two Fugu proteins and one zebrafish protein
clustered on a separate branch between FAM20A and
FAM20B. In order to determine the subfamily to which
these proteins belonged, we made use of the high degree
of conservation of exon size and number noted in the
mammalian genes (Figure 3C). The exon number and size
of the Fugu and zebrafish genes encoding the two proteins
assigned to FAM20A and FAM20B were consistent with
their membership in these families. The only variations
noted were a slightly larger exon 2 in the Fugu Fam20a
gene and the division of exon 1 into two exons in the Fugu
Fam20b gene. As in the mammalian family members, the
sizes of the terminal exons varied more than the internal
exons. The other four Fugu genes displayed exon distribu-
tions consistent with membership in FAM20C, despite the
clustering of two of the encoded proteins between
FAM20A and FAM20B. We have assigned each of these
proteins to FAM20C with number suffixes (c1, c2, etc.) to
designate individual genes and proteins. Each of these
genes maps to distinct genomic loci and thus represents
independent genes and not splicing variants of a smaller
number of genes (data not shown). The gene structures of
the three zebrafish family members were also consistent
with this family assignment (data not shown). Compari-
sons of the derived protein sequences within each sub-
family are shown in figures 4,5,6.
Features of FAM20 proteins
All of the identified FAM20 protein sequences contain
putative signal sequences at their amino termini but no
other functional domains were unambiguously detected
using several different annotation search software pro-
grams. In order to search for potential functional
Sequence alignment of FAM20A protein sequences Figure 4
Sequence alignment of FAM20A protein sequences. The complete protein sequences of FAM20A members were com-
pared using the AlignX component of the VectorNTI sequence analysis suite of programs. Identical amino acids are outlined in 
yellow, and similar residues are indicates in light blue. Conserved regions 1, 2 and 3 are underlined (see below). Gaps are indi-
cated with dashes and the sequences are from human (H), mouse (M), rat (R) and puff erfish (F).
FAM20A
         1                                                                                                100 
H    (1) MPGLRRDRLLTLLLLGALLSADLYFHLWPQVQRQLRPRERPRGCPCTGRASSLARDSAAAASDPGTIVHNFSRTEPRTEPAGGSHSGSSSKLQALFAHPL 
M    (1) MPGLRRDRLLALLLLGALFSADLYFHLWPQVQRQLRPGERPAACPCSGRAPSASLHSAAASRDLGTASHNFSGALPRVEHPSRGHPAPRSKLQALFAHSL 
R    (1) MPGLRRDRLLALLLLGALFSADLYFHLWPQVQRQLGPGERPAGCPCSGRAPSTSLHSAAASRDPGTASHNFSGALPRVEHPSRGHPAPRSKLKALFAHSL 
F    (1) MTMMRRDRFFLVFTLAAVFSADLYFILLPKLQRMGQRSVRP--CSCSPDNITLPQHGGVATPQLSNWTS-----AQQRDGTGSEHAVTGSKLENLFSHPL 
         101                                                                                              200 
H  (101) YNVPEEPPLLGAEDSLLASQEALRYYRRKVARWNRRHKMYREQMNLTSLDP---PLQLRLEASWVQFHLGINRHGLYSRSSPVVSKLLQDMRHFPTISAD 
M  (101) YQVLEDPPLLGPEDWLLASQEALRYYRRKVARWNRRHKIYKEQFNLTSLDP---PLQFRPEASWVQFHLGINSHGLYSRSSLAISKLLHDMRHFPTISAD 
R  (101) YQVLEDPPLLGPEDWLLASQEALRYYRRKVARWNRRHRIYKEQFNLTSLDP---PVQFRPEASWVQFHLGINSHGLYSRSSPVVSKLLHDMRHFPTISAD 
F   (94) YSIQT--PELAPEERLLATGQLMEYYKKKVARWERHMKLYSEAAAVSNITVSEHKVTYDPDASWLKFHLGINRYALYSRDDPVIPQLLREMQSMTVISAD 
         201                                                                                              300 
H  (198) YSQDEKALLGACDCTQIVKPSGVHLKLVLRFSDFGKAMFKPMRQQRDEETPVDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPTVGRIVNVTKEILEVTK 
M  (198) YSQDEKALLGACDCSQIVKPSGVHLKLVLRFSDFGKAMFKPMRQQREEETPEDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPTVGRLVNVTKEILEVTK 
R  (198) HSQDEKALLGACDCSQIVKPSGVHLKLVLRFSDFGKAMFKPMRQQREEETPEDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPTVGRLLNVTKEILEVTK 
F  (192) YTQDEKALKGECDCTQVVKPSGHHLKLALKMETYAKAMFKPMRQQRHEETPEDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPVAGRVVNLTGEVLQVTH
         301                                                                                              400 
H  (298) NEILQSVFFVSPASNVCFFAKCPYMCKTEYAVCGKPHLLEGSLSAFLPSLNLAPRLSVPNPWIRSYTLAGKEEWEVNPLYCDTVKQIYPYNNSQRLLNVI 
M  (298) NEILQSVFFVSPANNVCFFAKCPYMCKTEYAVCGNPHLLEGSLSAFLPSLNLAPRLSVPNPWIRSYSLSGKEEWELNPLYCDTVKQIYPYNSSNRLLGII 
R  (298) NEILQSVFFVSPANNVCFFAKCPYMCKTEYAVCGNPHLLEGSLSAFLPSLNLAPRLSVPNPWIRSYSLSGKEEWELNPLYCDTVKQIYPYNSSNRLLGII 
F  (292) NEDLRSVFFTSPANNTCFFSKCLYVCKTEYAVCGNPDLLEGSLSAYLPSLSIAPRTSIPNPWIRSYTFTGREEWEVNPFFCDTVKQMYPYNSGNRLLNII 
         401                                                                                              500 
H  (398) DMAIFDFLIGNMDRHHYEMFTKFGDDGFLIHLDNARGFGRHSHDEISILSPLSQCCMIKKKTLLHLQLLAQADYRLSDVMRESLLEDQLSPVLTEPHLLA 
M  (398) DMAVFDFLIGNMDRHHYEMFTKFGDDGYLIHLDNARGFGRHSQDEISILAPLAQCCMIKRKTLLHLQLLAQADYRLSDVMRESLLEDQLSPVLTEPHLLA 
R  (398) DMAVFDFLIGNMDRHHYEMFTKFGDDGYLIHLDNARGFGRHSQDELSILAPLSQCCMIKRKTLLHLQLLAQAEYRLSDVMRESLLEDQLTPVLTEPHLLA 
F  (392) DMSIFDFLISNMDRHHYEVFSKFGEEGFPLHLDNARGFGKHSKDEISILSPLSQCCIIKSSTLLRLQLLSRPGYRLSDVMRESLEKDALQPILTEPHLLA
         501                                        546 
H  (498) LDRRLQTILRTVEGCIVAHGQQSVIVDGPVEQSAPDSGQANLTS-- 
M  (498) LDRRLQIILKTVEDCIEAHGERRVIAEGSAQRSAPDSGQANLTS-- 
R  (498) LDRRLQIILKTVEDCIEAHGERRVIADGSAQHSAPDSGQANLTS-- 
F  (492) LDRRLQKVLRAVQRCIRRLGKDRVVTEDFVQSTEGPQVATGLAKVR BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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domains, we compared the sequences of all family mem-
bers. These comparisons revealed that the greatest similar-
ity was located within the carboxy-terminal two thirds of
each protein (Figure 7A). We have named this region the
conserved C-terminal domain (CCD) and it overlaps with
a domain listed in the CDD database at NCBI as
DUF1193. The CCD contains three distinct regions that
are more highly conserved within all members of the fam-
ily than the surrounding sequences (named conserved
regions 1, 2 and 3 in figure 7A) and the consensus
sequences for each conserved region were derived (figure
7B). Amino acids that are essentially invariant in all fam-
ily members have been indicated in bold type and the
heptapeptide DRHHYE in CR2 is the longest contiguous
sequence that is conserved in all members of the family. A
set of eight cysteine residues is also perfectly conserved
within the CCD of each family member that may partici-
pate in inter-or intramolecular disulphide bond
formation.
Fam20a is a secreted protein
As the putative signal sequence was the only known
domain identified in all family members, we next tested
whether this sequence is functional. Signal sequences are
commonly found on proteins that are directed to the
endoplasmic reticulum (ER) and either retained there or
processed and transported into the Golgi apparatus and
secreted from the cell. Many proteins are glycosylated dur-
ing their transit through the ER and Golgi apparatus and
the mouse Fam20a protein contains four potential sites
Sequence alignment of FAM20B protein sequences Figure 5
Sequence alignment of FAM20B protein sequences. The complete protein sequences of FAM20B members are pre-
sented as described in figure 4. The sequences are from human (H), mouse (M), rat (R), pufferfish (F), zebrafish (D) and C. intes-
tinalis (Ci).
FAM20B
         1                                                                                                100 
H    (1) MKLKQRVVLLAILLVIFIFTKVFLIDNLDTSAANREDQRAFHRMMTGLRVELAP----KLDHTLQSP--------------------------------- 
C    (1) MKLKQRVVLLAILLVIFIFTKVFLIDNLDTSAANREDQRAFHRMMAGLRVELVP----KLDHTLQSP--------------------------------- 
M    (1) MKLKQRVVLLAILLVIFIFTKVFLIDNLDTSAANREDQRAFHRMMTGLRVELVP----KLDHTLQSP--------------------------------- 
R    (1) MKLKQRVVVLAILLVIFIFTKVFLIDNLDTSAANREDQRAFHRMMTGLRVELVP----KLDHTLQSP--------------------------------- 
F    (1) MKLKQRVVVLCAVLLLLGLAKIFLLDGGEGSAASRRDLRAFRRMEAGLSLSRGA----RLTHTLQSP--------------------------------- 
D    (1) MKLKQRVVVLCAVLFLLGLAKVFLLDGGEGSAASRRDLRAFRKMEASLSLAKGA----RLTHTLQSP--------------------------------- 
Ci   (1) MKLKQRIIIGMTCMVAWFTIYKMFQGVNDDEETILNDLRLAEKPIVPQKVIKNAENEQKPDDVIEKPNDVIENSPMFIKQDSAARNEFVQSELDRLQLDF 
         101                                                                                              200 
H   (64) -----------WEIAAQWVVPREVYPEETPELGAVMHAMATKKIIKADVGYKGTQLKALLILEGGQKVVFKPKRYSRDHVVEGEPYAGYDRHNAEVAAFH 
C   (64) -----------WEIAAQWVVPREVYPEETPELGAIMHAMATKKIIKADVGYKGTQLKALLILEGGQKVVFKPKRYNRDYVVEGEPYAGYDRHNAEVAAFH 
M   (64) -----------WEIAAQWVVPREVYPEETPELGAIMHAMATKKIIKADVGYKGTQLKALLILEGGQKVVFKPKRYSRDYVVEGEPYAGYDRHNAEVAAFH 
R   (64) -----------WEIAAQWVVPREVYPEETPELGAVMHAMATKKIIKADVGYKGTQLKALLTLEGGQKVVFKPKRYSRDYVVEGEPYAGYDRHNAEVAAFH 
F   (64) -----------WEIASQWVGPREVYPEETPELAAVLTSLSTARVERADVGYKGTQLKALLVLDGGQKVVFKPKRYGRDYVVEGEPYAGYDRHNAEVAAFH 
D   (64) -----------WEVAAQWVGPREVYPDETPELAAVLNALATAHVERADVGYKGTQLKALLVLDGGQKVVFKPKRYVRDYVVEGEPYAGYDRHNAEIAAFH 
Ci (101) QAADVSDFKKLYKVAGSWVNERQIYPYQHPELAAILKLMASAKIMKADALPKGTQIKLLLVLEGGQRVVFKQKRYARDHIIEGKPYDGYDRHNAEIAAFH
         201                                                                                              300 
H  (153) LDRILGFHRAPLVVGRFVNLRTEIKPVATEQLLSTFLTVGNNTCFYGKCYYCRETEPACADGDIMEGSVTLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
C  (153) LDRILGFRRAPLVVGRFVNLRTEIKPVATEQLLSTFLTVGNNTCFYGKCYYCRETEPACADGDTMEGSVTLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
M  (153) LDRILGFRRAPLVVGRYVNLRTEVKPVATEQLLSTFLTVGNNTCFYGKCYYCRETEPACADGDMMEGSVTLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
R  (153) LDRILGFRRAPLVVGRYVNLRTEVKPVATEQLLSTFLTVGNNTCFYGKCYYCRETEPACADGDMMEGSITLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
F  (153) LDRILGFRRAPLVVGRYVNLRTEIKPVATEQLLSTFLMQGNNTCFYGKCYYCRESEPACAEGELMEGSLTLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
D  (153) LDRILGFRRAPLVVGRFMNLRTEIKPVATDQLLSTFLMHGNNTCFYGKCYYCRETEPACAEGDVMEGSVTLWLPDVWP-LQKHRHPWGRTYREGKLARWE 
Ci (201) LDRILDYRRSPLVVGRVLNLKTEIMPVATTRLLDTFREKDGNICYFGVCLYCNEKNMACGDGDVIEGSVTLWLPEKWSVFEKLRHPYQRTYVDNRMARWE
         301                                                                                              400 
H  (252) YDESYCDAVKKTSP-YDSGPRLLDIIDTAVFDYLIGNADRHHYESFQDDEGASMLILLDNAKSFGNPSLDERSILAPLYQCCIIRVSTWNRLNYLKNGVL 
C  (252) YDESYCDAVKKTSP-YDSGPRLLDIIDTAVFDYLIGNADRHHYESFQDDEGASMLILLDNAKSFGNPSLDERSILAPLYQCCIIRVSTWNRLNYLKNGVL 
M  (252) YDESYCDAVKKTSP-YDSGPRLLDIIDTAVFDYLIGNADRHHYESFQDDEGASMLILLDNAKSFGNPSLDERSILAPLYQCCIIRVSTWNRLNYLKNGVL 
R  (252) YDESYCDAVKKTSP-YDSGPRLLDIIDTAVFDYLIGNADRHHYESFQDDEGASMLILLDNAKSFGNPSLDERSILAPLYQCCIIRVSTWNRLNYLKNGVL 
F  (252) YDESYCEAVKKMPP-YDAGPRLLDVIDTAVFDYLIGNADRHHYESFQDDGGASMLILLDNAKSFGNAALDERSILAPLYQCCMIRVSTWNRLNLLRGGAL 
D  (252) YDESYCEAVKKMPP-YDAGPRLLDVIDTSIFDYLIGNADRHHYESFQDDGGASMLILLDNAKSFGNPSLDERSILAPLYQCCMVRVSTWNRLNLLKGGVL 
Ci (301) KDETYCEKVVKHQPPYDRGTRLLDVTDAAVFDYLIGNADRHHYEIFKNKSKDAMLLMLDNAKSFGNPSHHEPSILAPLRQCCILRNSTWIKLQKLSGGVL
         401                                                     459 
H  (351) KSALKSAMAHDPISPVLSDPHLDAVDQRLLSVLATVKQCTDQFGMDTVLVEDRMPLSHL 
C  (351) KSALKSAMAHDPISPVLSEPHLDAVDQRLLSVLATVKQCTDQFGADTVLVEDRMPLSHL 
M  (351) KSALKSAMAHDPISPVLSDPHLDTVDQRLLNVLATIKQCTDQFGTDTVLVEDRMPLSHL 
R  (351) KSALKSAMAHDPIAPVLSDPHLDTVDQRLLNVLATIKQCTDQFGMDTVLVEDRMPLSHL 
F  (351) SSAMRQAMAFDPIHPVLAEPHLAALDRRLSAVAATVKQCMETHGPDNTLIEDRMNLPHP 
D  (351) SSAMRQATAHDPAFPVLTGAHLTALDRRLNGVLATVRQCMETQGSENTLIEDRMNLPHP 
Ci (401) TQLLEAAMANDPISPVLHPSHLNAVDVRLPTLIETMEKCIKDKTYNKVIIEKWNGL---BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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Sequence alignment of FAM20C protein sequences Figure 6
Sequence alignment of FAM20C protein sequences. The complete protein sequences of FAM20C members are pre-
sented as described in figure 4. The sequences are from human (H), mouse (M), rat (R), pufferfish (Fcl-4) and zebrafish (Dcl-3).
FAM20C
         1                                                                                                100 
H    (1) ------MKMMLVRRFRVLILMVFLVACALHIALDLLPRLERRGARP----SGEPGCSCAQPAAEVAAPGWAQVRGRPGEPPAASSAAGDAGWPNKHTLRI 
M    (1) ------MKMILVRRFRVLILVVFLLACALHIAVDLLPKLDRRATRS----SGEPGCSCAQPAAEAAGPGWAQARSRPGE-----SAGGDAGWPNKHTLRI 
R    (1) ------MKMILVRRFRVLILVVFLLACALHIAVDLLPKLDRRATRS----PGEPGCSCAQPAAEAAGPGWAQARSRPGE-----SAGGDAGWPNKHTLRI 
Fc1  (1) --------MILFRKFRVLILMVFLVACTMHIMIDLLPKLEKRGAGADGADGG---CQCAHHPGGES-QGWGKQRVRTAA---------EAGWPNKHTLRI 
Fc2  (1) ------MKMIFLRKFRFLILMVFLIACSMHIMIDLLPKLERQGS------SG---CSCSHTPDENP-QSWGKQSR-----------------PNKHTLRI 
Fc3  (1) -------MRRLNLAKSTRSIYLSLACLSLALHLLLAFFCLSILQ-----------TACILPPSSSTQDTDPVQHGSHPS--------------PLDAGRP 
Fc4  (1) ------MIWRLRSRSRTICLSLAVVTASLYLLLLLASHSVDLQP-----------CDALLPSKTHVLRDLAHQNLSPAG--------------VQDSAAT 
Dc1  (1) --------MILFRKFRVLILTVFLIACTMHIMIDLLPKLEKRAAGSSSSAGGGSGCSCAHTPGEEP-RSWGKQRAR-AA---------DPGWPNKHSLRL 
Dc2  (1) --------MILFRKFRVLILMVFLIACSMHIMIDLLPKLERRSG------SA---CSCSHTPSEEP-QNWAKHRAKPGS---------ESGWPNKHTLRI 
Dc3  (1) MFPSDFSTMRVCTRRRSLTLRVWLLIVFLSLHLLVVSLVLSVYH-----------TSCELPSTYGIQTTISFSTQNAST--------------SEITMAT 
         101                                                                                              200 
H   (91) LQDFSSDPSSNLSSHSLEKLPPAAEPAERALRGRDPGALRPHDPAHRPLLRDPGPRRSESPPGPGGDASLLARLFEHPLYRVAVPPLTEEDVLFNVNSDT 
M   (86) LQDFSSDPASNLTSHSLEKLPSAAEPVDHAPRGQEPRSPPPRDPAHRPLLRDPGPRPRVPPPGPSGDGSLLAKLFEHPLYQGAVPPLTEDDVLFNVNSDI 
R   (86) LQDFSSDPASNLTSHSLEKLPPAAEPVDHAPRGQELGSPPPRDSAHRPLLRDPGPGPRVPPHGPRGDGSLLAKLFEHPLYQGAVPPLTEGDVLFNVNSDI 
Fc1 (80) LQDFSNEPVSNLTSQSREKNAAAADRAEPRGRTGPSAGRRQ---EHKPLIGEASSARAVPS--------RLSALFEHPLYKVDLPPLTDDDTLFNVNMDI 
Fc2 (68) LQDFSNEPSSNGSSHSLERVAVPGDKTQALSGTEHHGQRGE---KKRQFIQDAAVTKKIPVKG-----SKLSALFDHPLYKRALPPLSDEDTLFNVNTDI 
Fc3 (69) RRKVRSSHPAGEDSFSGSEKKLTGGGRAAQE---------------------VK------------GRARLEALFRHPLYNLPRPPLQEDDWLLRVRTSE 
Fc4 (70) VHGNSSN------RDASSEVRGHADQARKSV---------------------ES------------GLSKLEALFNHPLYNLPCPPIPEEDLLLKVRPQV 
Dc1 (82) LQDFSNEPNSNLTSQSREK-VTERAGSEKQG----SGKRGL---MREADSRQRRTDVRVSS--------VLQSLFEHPLYRTVLPDLTEEDTLFNLNAEI 
Dc2 (74) LQDFSNEPSSNLTSHSLEKMMVG-ERAEALKRFEQLTG------DERRLATRDSAFKNAAVKG-----SRLSALFEHPLYTRPLPPLTDEDTLFNVNTDI 
Dc3 (76) TR-----------SVSKEMKMVDPTG----------------------------------------DLAKLDALFSHPLYNLPTPPVPDGDWLLKVRTKV 
         201                                                                                              300 
H  (191) RLSPKAAE-----------NPDWPHAG--AEGAEFLSPGEAAVDSYPNWLKFHIGINRYELYSRHNPAIEALLHDLSSQRITSVAMKSGGTQLKLIMTFQ 
M  (186) RFNPKAAE-----------NPDWPHEG--AEGAEFLPTGEAAVNLYPNWLKFHIGINRYELYSRHNPAIDALLRDLGSQKITSVAMKSGGTQLKLIMTFQ 
R  (186) RFNPRAAE-----------NPDWPLEG--AEGAEFLPTGEAAVDLYPNWLKFHIGINRYELYSRHNPAIDALLHDLGSQKITSVAMKSGGTQLKLIMTFQ 
Fc1(169) RFYPRAAG-----------NKGWHHEEGNEEEEDFPPTGEVAAESYPNWLRFHIGINRYELYSRRSPATDALLKDLVTQRITSVAMKSGGTQLKLIMTFQ 
Fc2(160) RFDPKAAE-----------DQGWNTE---GTVDEFSPTGELTAESYPNWLRFHIGINRYELYSRHNPVIDALLKDLITQKITSVAMKSGGTQLKLIMTFQ 
Fc3(136) QTEDGEHEGYEEEEAISADSEWWSTSE---EEGYDKMDWTNDVDTHPPWLRFHLGITRWELYDRRDPNLDQLTHYLATQRILNAVQKTGGTQLKLLMSFP 
Fc4(131) EASET-------------NSQIWVNDS---PEEDKGVPWSSNSGSHPPWLQFHLGISRWQLYPHQDPNMELLVQQLAKHRIVSAVQKSGGTQLKLVMSFP 
Dc1(166) RLYPKAAG-----------QQEWHNE-GNVEEEEFSPPGEANSESYPNWLRFHIGINRYELYSRHNPVITALLRDLLSQKISSVGMKSGGTQLKLIMSFQ 
Dc2(162) RFDPKAAE-----------NPEWNGE---SKDGDYAPTGEMSSDSYPNWLRFHIGINRYELYSRHNPVIDAMLKDLVSQRITSVAMKSGGTQLKLIMTFQ 
Dc3(125) KEQE-------------RSTQQWVSAN---DDGFDPILWNTSTDTHPPWLRFHLGISRWQMYQHKDPNLSALNQQLASHRIVSAVQKSGGTQLKLVMSFP 
         301                                                                                              400 
H  (278) NYGQALFKPMKQTREQETPPDFFYFSDYERHNAEIAAFHLDRILDFRRVPPVAGRMVNMTKEIRDVTRDKKLWRTFFISPANNICFYGECSYYCSTEHAL 
M  (273) NYGQALFKPMKQTREQETPPDFFYFSDYERHNAEIAAFHLDRILDFRRVPPVAGRMINMTKEIRDVTRDKKLWRTFFVSPANNICFYGECSYYCSTEHAL 
R  (273) NYGQALFKPMKQTREQETPPDFFYFSDYERHNAEIAAFHLDRILDFRRVPPVAGRMINMTKEIRDVTRDKKLWRTFFVSPANNICFYGECSYYCSTEHAL 
Fc1(258) NYGQALFKPMKQTREQETPPDFFYFSDFERHNAEIAAFHLDKILDFRRVPPVAGRLVNMTREIRDVTRDKKLWRTFFISPANNVCFYGECSYYCSTEHAL 
Fc2(246) NYGQALFKPMKQTREQETPPDFFYFSDFERHNAEIAAFHLDRVLDFRRVPPVAGRLVNMTKEIRDVTRDKKLWRTFFISPANNVCFYGECSYYCSTEHAL 
Fc3(233) NHGQALLKPMKQSRQAETDVNLFYFSDFERHNAEIAAFHLDRLLGFHRVPPVVGRLINVTTEIREITTDHKLMKTFFTSPAGNVCFYGQCEYYCSTEHPV 
Fc4(215) NYGQALFKPMKQERDEETNYNLYYFSDFERHNAEIAAFHLDRILGYRRIPPAVGRLVDVVKEIKNVTTDRKLARTFFTSPVGSVCFYGLCSYYCSTEHAV 
Dc1(254) NYGQALFKPMKQTREQETPPDFFYFSDFERHNAEIAAFHLDRILDFRRVPPVAGRLVNMTREIRDVTRDKKLWRTFFVSPANNICFYGECSYYCSTEHAL 
Dc2(248) NYGQALFKPMKQTREQETPPDFFYFSDFERHNAEIAAYHLDRILDFRRVPPVAGRLVNMTKEIRDVTRDKKLWRTFFISPANNICFYGECSYYCSTEHAL 
Dc3(209) NYGQALFKPMKQERHEETNVNLYYFSDFERHNAEIAAFHLDRILGFRRIPPVIGRLINVIKEIKEVTTDHKLVTTFFNSPVGNTCFHGHCSYYCSTEHAV
         401                                                                                              500 
H  (378) CGKPDQIEGSLAAFLPDLSLAKRKTWRNPWRRSYHKRKKAEWEVDPDYCEEVKQTPPYDSSHRILDVMDMTIFDFLMGNMDRHHYETFEKFGNETFIIHL 
M  (373) CGRPDQIEGSLAAFLPDLSLAKRKTWRNPWRRSYHKRKKAEWEVDPDYCEEVKQTPPYDSGHRILDIMDMTVFDFLMGNMDRHHYETFEKFGNETFIIHL 
R  (373) CGKPDQIEGSLAAFLPDLSLAKRKTWRNPWRRSYHKRKKAEWEVDPDYCEEVKQTPPYDSGHRILDIMDMTVFDFLMGNMDRHHYETFEKFGNETFIIHL 
Fc1(358) CGKPDQIEGSLAAFLPDLNLAKRKTWRNPWRRSYHKRKKAEWEVDPDYCDEVKQTPPYDRGTRLLDVMDMTVFDFLMGNMDRHHYETFEKFGNDTFIIHL 
Fc2(346) CGKPDQIEGSLAAFLPDLALAKRKTWRNPWRRSYHKRKKAEWEVDPDYCEEVKQTPPYDSGTRLLDIMDMTIFDFLMGNMDRHHYETFEKFGNETFIIHL 
Fc3(333) CGRPHLLEVSLAAMLPDLTLAPRRSWRSPWKRSYSRTKLAQWEKVPAYCDTVKQTPPYNRGTRLVDLIDMAVLDFLMSNMDRHHYETFEKFGNDTFLVHL 
Fc4(315) CGHPTGLEASLAVMLPDLSLAKRRSWRSPWRRSYSRSKLAKWETQSNYCAKVKKTPPYNEGTRLVDFMDMVILDFLMSNMDRHHYETFEKFGNYTFLLHL 
Dc1(354) CGKPDQIEGSLAAFLPDLALAKRKTWRNPWRRSYHKRKKAEWEVDPDYCDEVKQTPPYDRGTRLLDIMDMTIFDFLMGNMDRHHYETFEKFGNDTFIIHL 
Dc2(348) CGKPDQIEGSLAAFLPDLSLAKRRTWRNPWRRSYHKRKKAEWEVDPDYCEEVKQTPPYDSGTRLLDIMDMTIFDFLMGNMDRHHYETFEKFGNETFIIHL 
Dc3(309) CGRPIKLEGSLAVMLPDLSLAPRHSWRSPWRRSYSRTNQAEWETNSNYCDTVKQTPPYDRGTRLVDVIDMSILDFLMSNMDRHHYETFEKFGNDTFLIHL
         501                                                                                              600 
H  (478) DNGRGFGKYSHDELSILVPLQQCCRIRKSTYLRLQLLAKEEYKLSLLMAESLRGD---QVAPVLYQPHLEALDRRLRVVLKAVRDCVERNG--LHSVVDD 
M  (473) DNGRGFGKYSHDELSILAPLHQCCRIRRSTYLRLQLLAKEEHKLSLLMAESLQHD---KVAPVLYQLHLEALDRRLRIVLQAVRDCVEKDG--LSSVVED 
R  (473) DNGRGFGKYSHDELSILAPLHQCCRIRRSTYLRLQLLAKEEYKLSLLMAESLQHD---KVAPVLYQLHLEALDRRLRIVLQAVRDCVEKDG--VSSVVED 
Fc1(458) DNGRGFGKHSHDELSILVPLSQCCRVRKSTYQRLQLLAKEDYRLSALMEESLLQD---RLSPVLIQPHLQAMDRRVQVVLQVLEGCIEKEG--YANVVEE 
Fc2(446) DNGRGFGKHSHDEMSILVPLTQCCRVRKSTHLRLQLLAKEEYKLSTLMAESLVRD---HLSPILIQPHLEAMDRRLRQILNVLSECIEKEG--YSYVVED 
Fc3(433) DHGRAFGRHSQDEPSILAPLQQCCRIRRSTLLRLRLLSLPDSRLSDMMRASLARDPLAAVAPILSEPHLSALDRRLATVLQVVRTCQHQHQ----DVIYD 
Fc4(415) DNGRAFGRHSKDESSILAPLEQCCRIRRSTWLRLRLLSLPQYRLSDIMRASLSQDPLHRVAPLLSDPHLVALDRRLKTVLETVDHCQRRLSEGGGEVIFD 
Dc1(454) DNGRGFGKHSHDEMSILVPLTQCCRVKRSTYLRLQLLAKEEYKLSSLMEESLLQD---RLVPVLIKPHLEALDRRLRLVLKVLSDCVEKDG--FSAVVEN 
Dc2(448) DNGRGFGKHSHDELSILVPLSQCCRVKKSTHLRLQLVAKEEFKLSSLMEESLQTD---TLSPILIRPHLEAMDRRLRLVLQVLADCIEKEG--YSNVVED 
Dc3(409) DNGRAFGRHSKDEPSILAPLVQCCRVRRSTLLRLRLLSLPPYRLSDVMRASLSRDPLAEVAPLLTEPHLSALDRRLETVMQAIQDCLQQHQHHS-DVIYD
         601            618 
H  (573) DLDTEHRAASAR------ 
M  (568) DLATEHRASTER------ 
R  (568) DLATEHRASTER------ 
Fc1(553) DLVRDTATHRSPGHR--- 
Fc2(541) DLQEQQGTDHVPTSPRWR 
Fc3(529) DLGKYEEDQNQQPDGKNK 
Fc4(515) DVKDVATYVG-------- 
Dc1(549) DLDGQPSVHGGR------ 
Dc2(543) DMG-TEGMDTGTVPQR-- 
Dc3(508) DIMDYPQA---------- BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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for N-glycosylation (indicated in red type in figure 1). As
Fam20a does not contain an ER retention signal, we pre-
dicted that it should be detected in the medium of
expressing cells. A mammalian expression vector was con-
structed that contained the full length mouse Fam20a
coding sequence fused to a C-terminal Myc epitope tag
and a hexahistidine sequence to permit purification. The
plasmid was transfected into monkey kidney COS-1 cells
and total protein was isolated from both the cells and the
cell medium. Proteins in the cell medium were first proc-
essed on a Nickel column to isolate and concentrate the
recombinant Fam20a protein and both protein samples
were analyzed by immunoblotting using an antiserum
specific for the Myc epitope. The predicted molecular
weights of the full length and processed forms of Fam20a
are 61,500 and 57,500, respectively, and a recombinant
form of the protein synthesized in rabbit reticulocyte
lysates was run alongside as a molecular size marker. The
recombinant protein migrated just below the 62,000
mol.wt. size marker (Figure 8A and 8B, lane 5); however,
the proteins detected in both the cell medium and cell
extract migrated slower (lane 3). To test whether this
slower migrating band represented a glycosylated form of
Fam20a, the protein samples were treated with the
enzyme N-glycosidase F (PNGaseF). The protein detected
after enzyme treatment migrated more rapidly than the
untreated protein and comigrated with the recombinant
form of the protein (compare lanes 3, 4 and 5). We noted
a second band that migrated slightly more slowly than the
recombinant protein in the PNGase F treated cell extracts
that may represent an alternatively modified form of
Fam20a (Figure 8B, lane 4). To confirm that Fam20a is a
secreted protein, we also exposed Fam20a-expressing cells
to Brefeldin A, a fungal metabolite that specifically blocks
transport from the ER to the Golgi apparatus, and exam-
ined the effects on Fam20a secretion. Brefeldin A treat-
ment resulted in a consistent decrease in the amount of
Fam20a detected in the cell medium (Figure 8C, compare
lanes 5 and 6). Thus, Fam20a is a secreted glycoprotein.
Fam20a secretion requires a functional signal sequence
We next tested whether the integrity of the signal sequence
was required for Fam20a secretion. Signal sequences typi-
cally contain a high proportion of hydrophobic amino
acids and 19 of the first 34 amino acids of Fam20a are
hydrophobic (Figure 9A). Therefore, we expressed a
Fam20a protein lacking the first 23 amino acids
(FAM20a(∆23)) in COS-1 cells and examined secreted
and intracellular proteins by immunoblotting (Figure
9B). Glycosylated FAM20a(∆23) protein was not detected
in the medium (compare lanes 2 and 3) and immunore-
activity that comigrated with the unglycosylated recom-
binant protein was detected in the cell extract (lane 6). We
also compared the subcellular location of the
Schematic representation of the structural features of FAM20 family members Figure 7
Schematic representation of the structural features of FAM20 family members. A. Structural features of FAM20A 
showing domains and residues conserved within the entire family. Key: SS: signal sequence; CCD: conserved C-terminal 
domain; CR: conserved region; Cys: cysteine residues conserved within CCD (indicated with asterisk). B. Consensus 
sequences were derived for CR1, CR2 and CR3 using a global comparison of all the family members listed in Tables 1 and 2. 
Residues that are invariant or only differ in one sequence are indicated in bold. Non-conserved residues are indicated with an 
x and positions with more than one common residue are shown below the main sequence.
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Fam20a is a secreted protein Figure 8
Fam20a is a secreted protein. COS-1 cells were transfected with either an empty expression vector (-) or one encoding 
mouse Fam20a with a C-terminal myc epitope tag and proteins were isolated from either the medium (panel A) or the cells 
(panel B). The proteins were analyzed by immunoblotting using a Myc tag-specific antiserum. Samples in lanes 2 and 4 of each 
blot were pre-treated with protein N-glycosidase prior to analysis to remove glycosyl groups. A recombinant form of Fam20a 
synthesized in rabbit reticulocyte lysates (TnT) was included on each gel as a size marker. The position of glycosylated and 
deglycosylated Fam20a is indicated using arrowheads and cross reacting material detected in the medium is indicated using 
asterisks. The location of molecular size markers is shown on the left of each gel. C. Protein samples from the medium of 
transfected cells that were untreated or treated with Brefeldin A were analyzed by immunoblotting using the Myc tag-specific 
antiserum. As Brefeldin A was resuspended in DMSO, the untreated cells were exposed to DMSO alone as a vehicle control. 
The amount of Fam20a detected in the medium of Brefeldin A treated cells was consistently lower than that observed in 
untreated cells (indicated using an arrowhead).BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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Secretion of Fam20a requires an intact signal sequence Figure 9
Secretion of Fam20a requires an intact signal sequence. A. Schematic representation of the putative signal sequence of 
Fam20a. The predicted cleavage site is indicated with a red arrowhead. The two amino acid substitutions introduced in the 
SSmut construct and the sequence remaining in the ∆23 mutant construct are shown. B. Immunoblot analysis of Fam20a and 
Fam20a(∆23) protein levels in transfected COS-1 cells. The position of the glycosylated form of Fam20a (which is absent in 
Fam20a(∆23) transfected cells is indicated with an arrowhead. C. Fluorescence images of COS-1 cells expressing either 
Fam20a-GFP or Fam20a(∆23)-GFP. The wild type protein was observed within the cytoplasm, predominantly in a structure 
that is likely to be the ER. The mutant protein was primarily localized to the nucleus. D. Immunofluorescence images of Fam20a 
and Fam20a (SSmut) proteins as detected by antiserum directed against the C-terminal Myc epitope. The wild type protein was 
again detected in the ER and the mutant protein primarily in the nucleus. The cells have been counterstained with DAPI to 
delineate the nucleus.
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RT-PCR analysis of mouse Fam20 mRNA levels during differentiation of EML and MPRO cells Figure 10
RT-PCR analysis of mouse Fam20 mRNA levels during differentiation of EML and MPRO cells. Total RNAs were 
prepared from EML (panel A) or MPRO (panel B) cells at the indicated timepoints during myeloid and granulocytic differentia-
tion. cDNAs prepared from each sample were amplified using primer pairs specific to each mouse family member. The PCR 
products were analyzed by agarose gel electrophoresis and stained using Gelstar SYBR Green DNA stain. GAPDH was used as 
a loading control.BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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FAM20a(∆23) protein to the wild type protein using GFP
fusion proteins (figure 9C). The wild type Fam20a-GFP
proteins displayed perinuclear and cytoplasmic staining
consistent with ER localization. In contrast, the Fam20a
(∆23)-GFP protein was absent from the cytoplasm and
appeared to be exclusively localized within the nucleus.
To ensure that this effect was not a consequence of a gross
change in protein structure due to the deletion of 23
amino acids, we also constructed an expression vector
encoding a Fam20a protein with a two amino acid substi-
tution within the putative signal sequence (Figure 9A).
These changes (Leu14–Leu15 to Asp-Glu) were predicted to
disrupt the signal sequence without grossly altering the
protein structure. Again the mutant protein displayed
nuclear staining and was absent from the ER (Figure 9D).
These results confirm that an intact signal sequence was
necessary for secretion of Fam20a and that secretion was
accompanied by prominent localization of the protein to
the ER.
Expression patterns of FAM20 genes during myeloid 
differentiation
We originally identified Fam20a as a differentially
expressed mRNA in EML cells induced to differentiate
along the myeloid lineage. To determine whether Fam20b
and Fam20c are also expressed during hematopoiesis, we
performed RT-PCR analysis of cDNAs prepared at various
times during experimentally-induced differentiation of
EML and MPRO cells using primers specific to each family
member. Fam20a mRNA levels were low in uninduced
EML cells maintained in the presence of SCF and
increased during the subsequent 72 hours of incubation
in atRA and IL-3 (Figure 10A). EML cells mature to the
promyelocyte stage of neutrophil differentiation under
these conditions and can subsequently be differentiated
into neutrophils by adding GM-CSF in place of SCF and
IL-3. Fam20a mRNA levels decreased during terminal
neutrophil differentiation in EML cells and also in MPRO
cells induced to undergo the same differentiation process
in the presence of atRA (Figure 10A and 10B). Fam20b
and Fam20c mRNAs were readily detected in both cell
lines and their levels did not vary dramatically during the
differentiation process in either cell line (Figure 10A and
10B).
Expression patterns Of FAM20 genes in human tissues
Although we originally isolated Fam20a from a hemat-
opoietic cell line, cDNAs and ESTs derived from each of
the FAM20 family members have been isolated from non-
hematopoietic tissues (data not shown). Therefore, we
examined the expression patterns of the three genes in a
panel of cDNAs derived from various human tissues.
FAM20A displayed the most restricted expression pattern
with high levels in lung and liver and intermediate levels
in thymus and ovary (Figure 11). Low levels of FAM20A
mRNA were detected in several other tissues. FAM20B and
FAM20C were expressed in a wider variety of tissues and
their expression patterns were very similar.
Discussion
Several classes of secreted proteins, including the colony
stimulating factors or hematopoietins, are important
regulators of hematopoietic differentiation and function
[11]. These molecules are of clinical significance due to
their use in stimulating hematopoiesis in patients with
neutropenias and other hematological disorders [11].
Consequently, the identification of novel secreted pro-
teins that display specific spatiotemporal expression
patterns in hematopoietic cells is of great interest. In this
report, we describe the identification and initial character-
ization of a new family of secreted glycoproteins
expressed within the hematopoietic lineage as well as sev-
eral other cell types and tissues. The family has been
named FAM20 to indicate the fact that the members are
related by sequence similarity rather than a specific shared
function and contains three members in mammals. We
anticipate that the members will acquire new names as
their specific functions are determined. The family
contains three separate subfamilies which are referred to
as FAM20A, FAM20B and FAM20C in humans.
FAM20 proteins: features and potential functions
At the present time, the specific function(s) of the FAM20
proteins is unknown. Analysis of the sequences of the pro-
teins from various species failed to reveal obvious similar-
ities to known functional domains except for an N-
terminal signal sequence. Expression studies clearly
demonstrated that the mouse Fam20a protein is a secreted
protein and that disruption of the signal sequence pre-
vented the detection of the glycosylated form of the pro-
tein in cell media. Surprisingly, disruption of the signal
sequence resulted in redistribution of intracellular
Fam20a from a cytoplasmic compartment that is likely to
be the ER to the nucleus. It is unclear whether this redis-
tribution is functionally significant and is presumably due
to the presence of a cryptic nuclear localization signal
(NLS) in the protein. NLSs are generally comprised of
stretches of basic residues [12] and several candidate
regions rich in basic amino acids are present in Fam20a
that could direct the mislocalized protein to the nucleus.
Overall, the FAM20 proteins vary in length between 400–
670 amino acids with the FAM20B family members being
the shortest and the FAM20C members generally being
the longest. The variation in length is due to differences in
the length of the less conserved N-terminal region. The
FAM20 proteins are further characterized by a highly con-
served C-terminal region of approximately 350 amino
acids that we named the conserved C-terminal domain
(CCD). We noted the presence of three regions that areBMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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more highly conserved amongst all family members, with
the most invariant extended sequence being the DRHHYE
heptapeptide within conserved region 2. The function of
the peptide is as yet unknown but three possible functions
can be proposed. First, the histidines within this sequence
could be involved in the coordination of metal ions that
may be required for FAM20 protein function. Second,
FAM20 proteins may be enzymes and this sequence may
be a component of the active site of the enzyme. Interest-
ingly, a weak match was detected between this region of
certain FAM20 family members and a conserved domain
within the phosphatidylinositol 3- and 4-kinases [13];
however additional experiments must be performed to
address the relevance of this similarity. Third, the highly
charged nature of this peptide suggests that it may be
located on the surface of FAM20 proteins, where it may
participate in protein:protein interactions. Although we
have been unable to identify any other proteins in public
databases that contain the exact sequence, the sequence
RHHYE is found between amino acids 41–45 in the N-ter-
minal region of the viral infectivity protein (Vif) from
human immunodeficiency virus 1 (Accession number
AAQ09611) [14]. Vif enhances HIV-1 infectivity by block-
ing the antiviral activity of the nucleotide editing enzyme
APOBEC3G [15]. Vif exerts its inhibitory effect by binding
to and inducing the degradation of APOGEC3G and also
by blocking its translation [16,17]. The APOBEC3G inter-
acting domain is located within the N-terminal region
that contains the FAM20-related pentapeptide although
the specific involvement of this sequence has not yet been
investigated [16]. Thus, this sequence within conserved
region 2 may be a site for protein:protein interaction.
However, APOBEC3G or related proteins are unlikely can-
didate binding partners as they are intracellular proteins.
We also noted that one of the Drosophila FAM20 proteins
(NM_170079; CG31145) was identified as a protein that
interacted with the Dynein light chain protein Dlc90f
[18]. Dyneins are motor proteins involved in intracellular
RT-PCR analysis of human FAM20 mRNA levels in human tissues Figure 11
RT-PCR analysis of human FAM20 mRNA levels in human tissues. A panel of commercially available human cDNAs 
prepared from the indicated tissues was analyzed by PCR using primer pairs specific for each of the human FAM20 family mem-
bers. GAPDH was again used as a loading control although large variations were observed in the GAPDH signal in the different 
tissues.BMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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transport [19]. It appears unusual that a secreted protein
would directly interact with a motor protein; therefore,
this may represent a specific interaction of this particular
family member in fruitfly.
Evolution of the FAM20 gene family
Tremendous progress has been made over the past decade
in the sequencing of genomes from species at different
positions on the evolutionary tree [20-25]. This vast
amount of information can be used for comparative stud-
ies to elucidate the evolutionary origin of members of
gene families. We have reported here the identification of
orthologues of the FAM20 members in two insect species
(D. melanogaster and A. gambiae), a simple chordate (C.
intestinalis), three mammals (H. sapiens, M. musculus and
R. norvegicus) and two fish (F. rubripes and D. rerio). In
each case, the identification of these genes as bona fide
transcription units is supported either by direct experi-
mental evidence for the human and mouse genes, or by
the existence of multiple EST sequences in public data-
bases. A single FAM20 gene was identified in C. intestina-
lis, which is considered to be a representative of a basal
chordate related to the common ancestor of humans and
other higher chordates [10]. The C. intestinalis genome
encodes approximately 16,000 genes and generally con-
tains single representatives of superfamilies in higher ver-
tebrates, thereby permitting the elucidation of likely
evolutionary origins of genes within these families [9].
The C. intestinalis FAM20 protein clustered with the
FAM20B subfamily members, as did the family members
identified in invertebrate species. Therefore, we propose
that the FAM20B subfamily contains the direct descend-
ents of the ancestral FAM20 gene and that the FAM20A
and FAM20C subfamilies result from duplication and
subsequent evolution of this ancestral gene [26]. This pat-
tern is consistent with the 2R hypothesis of genome evo-
lution proposed by Ohno in 1970 [27]. In the FAM20
case, the loss of one gene at some stage of higher verte-
brate evolution would need to be hypothesized to explain
the final paralogue number of three in mammals. A single
round of gene duplication appears to have occurred sub-
sequent to the divergence of the nematode and insect lin-
eages, giving rise to the two paralogues in fruit fly and
mosquito that both cluster within the FAM20B subfamily.
A further round of gene duplication has been proposed to
have occurred in fish [28] and the existence of five to six
FAM20 genes in pufferfish and zebrafish is consistent with
this hypothesis. However, it is interesting that the
expansion appears to have occurred exclusively in the
FAM20C subfamily. This pattern could be explained
either by two successive rounds of gene duplication of a
small genomic region that included the original FAM20C
representative, or by two rounds of duplication of larger
genomic segments followed by gene conversion of
FAM20A and FAM20B descendents (or parents) to yield
four FAM20C members. Analysis of the genomic regions
surrounding each of the FAM20C genes in fish will be nec-
essary to distinguish between these two possibilities. Nev-
ertheless, the expansion of the FAM20C subfamily in fish
suggests that these proteins have acquired specific func-
tions required within these species.
FAM20 expression patterns in mammalian cells and tissues
Expression analysis of the three FAM20 family members
in mammalian tissues and hematopoietic cells showed
that FAM20A is expressed in a much more restricted pat-
tern that the other two members. Importantly, Fam20a
was also the only member to display obvious differential
expression in hematopoietic cells undergoing myeloid
differentiation. Fam20a mRNA levels were highest during
intermediate stages of differentiation of EML cells, at a
time when many cells are becoming committed to the
myeloid lineages and undergoing extensive proliferation
[4,8,29]. EML cell cultures also give rise to a small number
of cells from B cell and erythroid lineages under these con-
ditions but these cells do not survive after SCF and IL-3 is
removed from the medium and replaced with GM-CSF.
Thus, the decrease in Fam20a mRNA levels after the 72
hour timepoint could be interpreted in two ways. First,
Fam20a may be expressed in one of the lineages that can-
not survive in GM-CSF. Second, Fam20a may be expressed
specifically in cells committed to the myeloid lineage and
its expression may decrease during terminal granulocytic
differentiation. The similarities in Fam20a expression pat-
terns in EML cells after the 72 hour timepoint and in
MPRO cells suggests that the second explanation is most
likely. Therefore, we propose that Fam20a is primarily
expressed in cells committed to the granulocytic lineage
and presumably plays a role in either lineage commit-
ment of cell proliferation. The hypothesis is currently
under investigation using gene disruption techniques and
through further characterization of the Fam20a protein.
Methods
Cell culture and Representational Difference Analysis 
(RDA)
EML and MPRO cells were cultured as described previ-
ously [6,30]. Briefly, EML cells were cultured in Iscove's
modified Dulbecco's medium containing 20% horse
serum (Atlanta Biochemical, Norcross, GA) supple-
mented with 10% BHK-MKL conditioned medium (CM)
as a source of stem cell factor (SCF). The cells were differ-
entiated by adding 10% of WEHI-3 CM as a source of IL-
3 and all trans retinoic acid (atRA, 1 × 10-5 M, Sigma) for
72 hours. Terminal granulocytic differentiation was
induced by removing IL-3 and SCF and adding 10% BHK-
HM5 CM as a source of granulocyte/macrophage-colony
stimulating factor (GM-CSF). MPRO cells were cultured in
Dulbecco's modified Eagle's medium supplemented withBMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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10% fetal bovine serum (FBS, Hyclone, Logan, UT) and
10% BHK-HM5 CM. Terminal differentiation was
induced by adding 1 – 10-5 M atRA to the culture medium.
For collection of RNA samples at different timepoints, 10
cm dishes were seeded with 150,000 cells and cultured
under identical conditions. Cells were harvested from
individual wells at 24 hour intervals for RNA preparation.
Total RNA was prepared from isolated cells using a modi-
fied guanidium isothiocyanite/phenol extraction proce-
dure as described previously [31]. Poly A+ RNA prepared
from EML cells at zero hours (stem cell stage) and 72
hours (promyelocyte stage) was converted to double
stranded cDNA and three rounds of RDA was performed
as described previously [6]. cDNA clones representing six
putative differentially expressed genes were identified and
named according to clone number. Initial characteriza-
tion of these clones was described earlier [6,8] and clone
number 1623 was examined further in this study.
Cos-1 cells were maintained in Dulbecco's modified
Eagle's medium (DMEM, BioWhittaker, Walkersville,
MD) containing 10% FBS and Penicillin/Streptomycin
(BioWhittaker) under standard cell culture conditions.
For transfections, cells were plated at a density of 2.5 × 104
per well in six well plates and transfected using the Effect-
ene Transfection Reagent (Qiagen, Valencia, CA) under
conditions recommended by the manufacturer.
Isolation of a full length 1623 cDNA
Analysis of the sequence of the original 1623 cDNA iso-
lated from the RDA experiments revealed that it contained
the coding sequence from the C-terminus of an
uncharacterized protein. 5' and 3' rapid amplification of
cDNA ends (RACE) was performed using Marathon-
Ready cDNA from mouse spleen using the Advantage
cDNA PCR kit (both from Clontech) as described previ-
ously [30]. The RACE reactions were performed using
gene specific primers designed based on the original 1623
sequence or on sequences identified in early RACE reac-
tions and adaptor primers provided with the cDNA. The 5'
RACE products were compared to sequences in public
databases and identified a mouse cDNA (NM_017565;
aka DKFZp434F2322) that was identical to the extended
1623 sequence. PCR primers were designed that over-
lapped the putative initiation and stop codons of the ORF
encoded by NM_017565 and used to PCR amplify prod-
ucts from cDNAs prepared from undifferentiated MPRO
cells. The product of this PCR reaction was subcloned and
sequenced in its entirety. The sequence was identical to
the original clone (which was isolated from mammary tis-
sue) indicating that the same mRNA is expressed in both
tissues. The full length clone (now named Fam20a)
encoded a 541 amino acid protein.
Sequence analysis
All basic sequence manipulations were performed using
the VectorNTI suite of sequence analysis programs (Infor-
max/Invitrogen Corp., Carlsbad, CA). Identification of
FAM20 members from different species was initially
achieved using standard BLAST searches at NCBI http://
www.ncbi.nlm.nih.gov/BLAST/. Genome specific
searches were performed either through NCBI or Ensembl
http://www.ensembl.org/ or through genome specific
websites (Ciona intestinalis: http://genome.jgi-psf.org/
ciona4/ciona4.home.html;  Fugu rubripes: http://alumi
num.jgi-psf.org/prod/bin/blast.fugu3.cgi). Searches were
performed either as nucleotide-nucleotide (blastn)
searches or as protein-translated nucleotide (tblastn)
searches. In general, these searches were sufficient to iden-
tify gene regions encoding the most highly conserved
regions of the proteins, particularly in the fish and Ciona
genomes. To assemble complete genes, genomic regions
containing the identified regions of similarity were down-
loaded into VectorNTI and searches were performed for
individual exons, initially derived from mammalian genes
but subsequently, from potential orthologues in fish or
lower vertebrates, depending on the sequence being
examined. Putative exons were examined for the presence
of consensus splice donor and acceptor sites and complete
sets of exons were assembled into cDNAs for translation
and further comparisons. These results were compared
against genes assembled by two gene prediction pro-
grams, FGENESH: http://www.softberry.com/berry.phtml
and GENSCAN: http://genes.mit.edu/GENSCAN.html,
however, these programs often made incorrect assign-
ments that required manual assessment of the results. The
protein sequences derived from each of the examined
species were primarily used in the comparisons to define
subfamily assignments and alignments were performed in
the AlignX program in VectorNTI using the blosum62
scoring matrix. Protein domain searches were performed
using the Simple Modular Architecture Research Tool
(SMART) http://smart.embl-heidelberg.de/ and/or
Profilescan http://hits.isb-sib.ch/cgi-bin/PFSCAN. Signal
sequence searches were performed using the SignalP anal-
ysis program http://www.cbs.dtu.dk/services/SignalP/
[32]. Sequences derived by annotation of genome
sequences in this study have been submitted to the Third
Party Annotation database at NCBI under accession num-
bers BK001515 to BK001522. The FAM20 family name
has been approved by the Human Genome Organization
nomenclature committee.
Plasmid construction
The Fam20a and Fam20a∆23 were constructed in the
pEGFP-N1 vector by PCR cloning. XhoI and HindIII
restriction sites were engineered into the PCR primers
(Fam20a:
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5'GGCAAGCTTGCTCGTCAGATTAGCCTG3';
Fam20a∆23:
5'GGCCTCGAGGCCATGTACTTCCACCTCTGGCCG3'
and reverse primer was as above). Similar strategy was
used to clone Fam20a and Fam20a∆23 in the pcDNA3.1
vector (Forward primers were same as above; Fam20a and
Fam20a∆23 reverse primers:
5'GGCAAGCTTGGGCTCGTCAGATTAGCCTG3'). The
Fam20a(SSmut) was generated using a PCR-based site-
directed mutagenesis kit (Quickchange, Stratagene). All of
the sequences were verified by sequencing using an ABI
automated sequencer.
Western blotting
Whole cell extracts were prepared from transfected COS-1
cells by lysing directly in 2X Laemmli Sample Buffer as
described previously [31]. Purified His-tagged proteins
were prepared as described below and mixed with 2X Lae-
mmli Sample Buffer (120 mM Tris-HCl (pH 6.8), 10%
Glycerol, 3.3% SDS, 0.2 M dithiothreitol, 0.004%
Bromophenol Blue). Equal amounts of total cellular and
purified secreted proteins were separated by 12% SDS-
PAGE and transferred to nitrocellulose membranes
(Micron Separations, Westborough, MA). Membranes
were blocked in 5% non-fat milk in TBST (100 mM Tris-
HCl (pH 7.5), 0.9% NaCl, 0.1% Tween-20) for 1 hour.
Myc-tagged Fam20a proteins were detected using an anti-
myc mouse monoclonal antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA). Horseradish peroxidase-conju-
gated donkey anti-mouse antibody (Promega, Madison,
WI) was used for the secondary antibody. The immune
complexes were detected using SuperSignal chemilumi-
nescence detection kit (Pierce, Rockford, IL). In vitro tran-
scribed and translated Fam20a was generated using the
TnT T7 coupled reticulocyte lysate system (Promega) as
described previously [33].
Purification of His-tagged proteins from cell media
COS-1 cells were transfected as described above and
media were collected after 48 hours and mixed with
freshly made 10X binding buffer (500 mM NaH2PO4-
H2O (pH 8.0), 150 mM NaCl, 10 mM Imidazole). His-
tagged proteins were purified using Ni-NTA Magnetic Aga-
rose Beads (Qiagen, Valencia, CA) according to manufac-
turer's recommendations. Following the purification step
they were either used directly in western blot analysis or
for deglycosylation experiments. Purified proteins were
subjected to enzymatic deglycosylation using the
GlycoPro deglycosylation kit (ProZyme, San Leandro, CA)
following the manufacturer's protocol.
Immunofluorescence
COS-1 cells were plated on glass coverslips and trans-
fected with the indicated constructs the following day.
After 48 hours of incubation, the cells were fixed in 1%
formaldehyde for 30 minutes at room temperature. Cov-
erslips were incubated in PBS (137 mM NaCl, 2.7 mM
KCl, 4.3 mM Na2HPO4 (pH 7.3)) containing 1% Triton X-
100 for 10 minutes to permeabilize the cell membranes.
They were then transferred to PBST (PBS containing 0.1%
Tween-20) and incubated for 30 minutes. Mouse mono-
clonal anti-Myc antiserum (Santa Cruz) was used at
1:2,000 dilution in PBST containing 1% bovine serum
albumin (1 hour at room temperature). Coverslips were
then washed with PBST three times and incubated with
the secondary antibody (Alexa Fluor 488 [Molecular
Probes, Eugene, OR]) for 1 hour. Coverslips were washed
three times in PBST and once in water for 15 minutes
each, and were mounted on glass slides. The cells were
observed by epifluorescence microscopy using an Axiovert
135 TV microscope (Zeiss, Gottingen, Germany). Images
were captured with a Kodak DC290 zoom camera and
analyzed with MetaMorph 6.0 (Universal Imaging Corpo-
ration, Downingtown, PA).
Reverse transcription-polymerase chain reaction
Total RNA was purified as described above from EML and
MPRO cells at 24 hour timepoints during the differentia-
tion process of each cell line The primers were designed
using the Vector NTI sequence analysis suite of programs
(InforMax, Frederick, MD) and were follows: MmFam20a
forward 5'-catagaggcccacggcgagcg-3' and reverse 5'-
atggaatggggcaacag gggc-3'; Mmfam20b forward 5'-
tggacaggattctgggtttc-3' and reverse 5'-ccagggatgtcgatgtttct-
3'; MmFam20c forward 5'-agcagacgagagagcaggag-3' and
reverse 5'-cggatctccttggtcatgtt-3'; HsFAM20a forward 5'-
ctggcaggaaaagagtg-3' and 5'-cccgaacttggtgaacatct-3',
HsFAM20b forward 5'-ccctgaagagacaccagaagagc-3' and
reverse 5'-gaaacccagaatcctgtcca-3', HsFAM20c forward 5'-
ggctcacgttccacattggt-3' and reverse 5'-aaagtcagggggtgtctcct-
3'.; mouse glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward 5'-aatggtgaaggtcggtg tgaac-3' and
reverse 5'-gaagatggtgatgggcttcc-3'; human (GAPDH) for-
ward 5'-tgaaggtcggagtcaacggatttggt-3' and reverse 5'-catgt-
gggccatgaggtccaccac-3'. GAPDH was used as control for
cDNA integrity. Single stranded cDNA was reverse tran-
scribed from 2 µg of total RNA using 400 Units of Super-
script RNase H-  Reverse Transcriptase (Invitrogen,
Carlsbad, CA), 0.125 mM dNTPs, 10 mM DTT, and 1 µM
oligo (dT)15 in a total volume of 50 µl for 1 hour at 37°C.
2 ul of the RT reaction was then mixed with 1 ul of 10X
PCR Buffer (500 mM Tris-HCl (pH8.3), 2.5 mg/ml crystal-
line BSA and MgCl2  at 10, 20 or 30 mM (Idaho
Technology Inc., Idaho Falls, ID), 0.2 mM each dNTP,
0.05  µM of each primer and 1.25 Units Taq DNA
polymerase (Fisher Scientific, Pittsburgh, PA) in a total
volume of 10 µl. Reactions were loaded into a capillary
tube and PCR cycles were carried out using the Rapidcy-
cler Thermal cycler (Idaho Technology). Annealing tem-
peratures and Mg2+  concentrations were initiallyBMC Genomics 2005, 6:11 http://www.biomedcentral.com/1471-2164/6/11
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optimized for each primer. A commercial set of tissue
cDNAs, (Human Multiple Tissue cDNA (MTC) Panels,
Clontech, Palo Alto, CA) was used for the RT-PCR analysis
of human FAM20 family members.
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